NCT03762018 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 200
- group Id
- BG001
- value
- 200
- group Id
- BG002
- value
- 400
- units
- Participants
- groups
- description
- Atezolizumab 1200mg intravenously on day 1 every 3 weeks plus bevacizumab 15mg/kg intravenously on day 1 every 3 weeks plus 4-6 cycles of carboplatin AUC 5 plus pemetrexed 500mg/m\^2 intravenously on day 1 every 3 weeks
- id
- BG000
- title
- Atezolizumab Plus Bevacizumab Plus Chemotherapy
- description
- Bevacizumab 15mg/kg intravenously on day 1 every 3 weeks plus 4-6 cycles of carboplatin AUC 5 plus pemetrexed 500mg/m\^2 intravenously on day 1 every 3 weeks
- id
- BG001
- title
- Bevacizumab Plus Chemotherapy
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 42.3
- upper Limit
- 87.6
- value
- 70.7
- group Id
- BG001
- lower Limit
- 47.7
- upper Limit
- 88.2
- value
- 70.1
- group Id
- BG002
- lower Limit
- 42.3
- upper Limit
- 88.2
- value
- 70.4
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 40
- group Id
- BG001
- value
- 44
- group Id
- BG002
- value
- 84
- title
- Female
- measurements
- group Id
- BG000
- value
- 160
- group Id
- BG001
- value
- 156
- group Id
- BG002
- value
- 316
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 199
- group Id
- BG001
- value
- 200
- group Id
- BG002
- value
- 399
- title
- White
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Black
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 11
- group Id
- BG002
- value
- 26
- title
- Current smoker
- measurements
- group Id
- BG000
- value
- 99
- group Id
- BG001
- value
- 99
- group Id
- BG002
- value
- 198
- title
- Former smoker
- measurements
- group Id
- BG000
- value
- 86
- group Id
- BG001
- value
- 90
- group Id
- BG002
- value
- 176
- title
- Never smoked
- description
- Current smoker: Still smokes cigarettes, Former smoker: Smoked at least 100 cigarettes in the past during the whole life, Never smoker: Smoked 0-99 cigarettes during the whole life.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Smoking status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 80
- group Id
- BG001
- value
- 61
- group Id
- BG002
- value
- 141
- title
- 0
- measurements
- group Id
- BG000
- value
- 119
- group Id
- BG001
- value
- 139
- group Id
- BG002
- value
- 258
- title
- 1
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Unknown/Missing
- description
- 0: Fully active, able to carry on all pre-disease performance without restriction; 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- ECOG Performance Status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 43
- group Id
- BG001
- value
- 41
- group Id
- BG002
- value
- 84
- title
- IV
- measurements
- group Id
- BG000
- value
- 157
- group Id
- BG001
- value
- 159
- group Id
- BG002
- value
- 316
- title
- Other
- description
- Stage is based on the 8th TNM classification for Malignant Pleural Mesothelioma (American Joint Committee on Cancer) and is categorized here as "IV" (advanced stage) vs "Other" including the following stage categories: I (IA or IB), II, III (IIIA or IIIB).
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Stage
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 157
- group Id
- BG001
- value
- 154
- group Id
- BG002
- value
- 311
- title
- Epithelioid
- measurements
- group Id
- BG000
- value
- 43
- group Id
- BG001
- value
- 46
- group Id
- BG002
- value
- 89
- title
- Non pure epithelioid
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Histology
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 84
- group Id
- BG001
- value
- 89
- group Id
- BG002
- value
- 173
- title
- Yes
- measurements
- group Id
- BG000
- value
- 51
- group Id
- BG001
- value
- 58
- group Id
- BG002
- value
- 109
- title
- Possible
- measurements
- group Id
- BG000
- value
- 48
- group Id
- BG001
- value
- 33
- group Id
- BG002
- value
- 81
- title
- No
- measurements
- group Id
- BG000
- value
- 17
- group Id
- BG001
- value
- 20
- group Id
- BG002
- value
- 37
- title
- Unknown/Missing
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Asbestos exposure
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 117
- group Id
- BG001
- value
- 98
- group Id
- BG002
- value
- 215
- title
- <1
- measurements
- group Id
- BG000
- value
- 56
- group Id
- BG001
- value
- 66
- group Id
- BG002
- value
- 122
- title
- 1-49
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 26
- group Id
- BG002
- value
- 47
- title
- ≥50
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 16
- title
- Unknown/Missing
- param Type
- COUNT_OF_PARTICIPANTS
- title
- PD-L1 TPS%
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 146
- group Id
- BG001
- value
- 134
- group Id
- BG002
- value
- 280
- title
- Good prognosis
- measurements
- group Id
- BG000
- value
- 54
- group Id
- BG001
- value
- 66
- group Id
- BG002
- value
- 120
- title
- Poor prognosis
- description
- EORTC PROGNOSTIC SCORE: Curran et al. Journal of Clinical Oncology. 1998 Jan; Vol16:145-152
- param Type
- COUNT_OF_PARTICIPANTS
- title
- EORTC prognostic score
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 72
- group Id
- BG001
- value
- 64
- group Id
- BG002
- value
- 136
- title
- 0-Favorable
- measurements
- group Id
- BG000
- value
- 66
- group Id
- BG001
- value
- 63
- group Id
- BG002
- value
- 129
- title
- 1-Intermediate
- measurements
- group Id
- BG000
- value
- 62
- group Id
- BG001
- value
- 73
- group Id
- BG002
- value
- 135
- title
- 2-Poor
- description
- Mesothelioma risk score (MRS): Banna et al. Lung Cancer. 2022 Jul; 169:77-83 The risk factors are baseline systemic immune-inflammatory index (good: \< 1,250 vs poor: ≥ 1,250) and baseline haemoglobin (good: ≥ LLN vs poor: \< LLN) (LLN = 135 for males, LLN = 120 for females))
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Mesothelioma risk score (MRS)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 189
- group Id
- BG001
- value
- 187
- group Id
- BG002
- value
- 376
- title
- Yes
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 24
- title
- No
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Medical history
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 200
- group Id
- BG001
- value
- 200
- group Id
- BG002
- value
- 400
- units
- Participants
- groups
- description
- Atezolizumab 1200mg intravenously on day 1 every 3 weeks plus bevacizumab 15mg/kg intravenously on day 1 every 3 weeks plus 4-6 cycles of carboplatin AUC 5 plus pemetrexed 500mg/m\^2 intravenously on day 1 every 3 weeks
- id
- BG000
- title
- Atezolizumab Plus Bevacizumab Plus Chemotherapy
- description
- Bevacizumab 15mg/kg intravenously on day 1 every 3 weeks plus 4-6 cycles of carboplatin AUC 5 plus pemetrexed 500mg/m\^2 intravenously on day 1 every 3 weeks
- id
- BG001
- title
- Bevacizumab Plus Chemotherapy
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 42.3
- upper Limit
- 87.6
- value
- 70.7
- group Id
- BG001
- lower Limit
- 47.7
- upper Limit
- 88.2
- value
- 70.1
- group Id
- BG002
- lower Limit
- 42.3
- upper Limit
- 88.2
- value
- 70.4
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 40
- group Id
- BG001
- value
- 44
- group Id
- BG002
- value
- 84
- title
- Female
- measurements
- group Id
- BG000
- value
- 160
- group Id
- BG001
- value
- 156
- group Id
- BG002
- value
- 316
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 199
- group Id
- BG001
- value
- 200
- group Id
- BG002
- value
- 399
- title
- White
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Black
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 11
- group Id
- BG002
- value
- 26
- title
- Current smoker
- measurements
- group Id
- BG000
- value
- 99
- group Id
- BG001
- value
- 99
- group Id
- BG002
- value
- 198
- title
- Former smoker
- measurements
- group Id
- BG000
- value
- 86
- group Id
- BG001
- value
- 90
- group Id
- BG002
- value
- 176
- title
- Never smoked
- description
- Current smoker: Still smokes cigarettes, Former smoker: Smoked at least 100 cigarettes in the past during the whole life, Never smoker: Smoked 0-99 cigarettes during the whole life.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Smoking status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 80
- group Id
- BG001
- value
- 61
- group Id
- BG002
- value
- 141
- title
- 0
- measurements
- group Id
- BG000
- value
- 119
- group Id
- BG001
- value
- 139
- group Id
- BG002
- value
- 258
- title
- 1
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Unknown/Missing
- description
- 0: Fully active, able to carry on all pre-disease performance without restriction; 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- ECOG Performance Status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 43
- group Id
- BG001
- value
- 41
- group Id
- BG002
- value
- 84
- title
- IV
- measurements
- group Id
- BG000
- value
- 157
- group Id
- BG001
- value
- 159
- group Id
- BG002
- value
- 316
- title
- Other
- description
- Stage is based on the 8th TNM classification for Malignant Pleural Mesothelioma (American Joint Committee on Cancer) and is categorized here as "IV" (advanced stage) vs "Other" including the following stage categories: I (IA or IB), II, III (IIIA or IIIB).
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Stage
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 157
- group Id
- BG001
- value
- 154
- group Id
- BG002
- value
- 311
- title
- Epithelioid
- measurements
- group Id
- BG000
- value
- 43
- group Id
- BG001
- value
- 46
- group Id
- BG002
- value
- 89
- title
- Non pure epithelioid
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Histology
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 84
- group Id
- BG001
- value
- 89
- group Id
- BG002
- value
- 173
- title
- Yes
- measurements
- group Id
- BG000
- value
- 51
- group Id
- BG001
- value
- 58
- group Id
- BG002
- value
- 109
- title
- Possible
- measurements
- group Id
- BG000
- value
- 48
- group Id
- BG001
- value
- 33
- group Id
- BG002
- value
- 81
- title
- No
- measurements
- group Id
- BG000
- value
- 17
- group Id
- BG001
- value
- 20
- group Id
- BG002
- value
- 37
- title
- Unknown/Missing
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Asbestos exposure
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 117
- group Id
- BG001
- value
- 98
- group Id
- BG002
- value
- 215
- title
- <1
- measurements
- group Id
- BG000
- value
- 56
- group Id
- BG001
- value
- 66
- group Id
- BG002
- value
- 122
- title
- 1-49
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 26
- group Id
- BG002
- value
- 47
- title
- ≥50
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 16
- title
- Unknown/Missing
- param Type
- COUNT_OF_PARTICIPANTS
- title
- PD-L1 TPS%
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 146
- group Id
- BG001
- value
- 134
- group Id
- BG002
- value
- 280
- title
- Good prognosis
- measurements
- group Id
- BG000
- value
- 54
- group Id
- BG001
- value
- 66
- group Id
- BG002
- value
- 120
- title
- Poor prognosis
- description
- EORTC PROGNOSTIC SCORE: Curran et al. Journal of Clinical Oncology. 1998 Jan; Vol16:145-152
- param Type
- COUNT_OF_PARTICIPANTS
- title
- EORTC prognostic score
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 72
- group Id
- BG001
- value
- 64
- group Id
- BG002
- value
- 136
- title
- 0-Favorable
- measurements
- group Id
- BG000
- value
- 66
- group Id
- BG001
- value
- 63
- group Id
- BG002
- value
- 129
- title
- 1-Intermediate
- measurements
- group Id
- BG000
- value
- 62
- group Id
- BG001
- value
- 73
- group Id
- BG002
- value
- 135
- title
- 2-Poor
- description
- Mesothelioma risk score (MRS): Banna et al. Lung Cancer. 2022 Jul; 169:77-83 The risk factors are baseline systemic immune-inflammatory index (good: \< 1,250 vs poor: ≥ 1,250) and baseline haemoglobin (good: ≥ LLN vs poor: \< LLN) (LLN = 135 for males, LLN = 120 for females))
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Mesothelioma risk score (MRS)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 189
- group Id
- BG001
- value
- 187
- group Id
- BG002
- value
- 376
- title
- Yes
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 24
- title
- No
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Medical history
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle